𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Active vitamin D and its analogs as drugs for the treatment of osteoporosis: advantages and problems

✍ Scribed by Yasuho Nishii


Publisher
Springer
Year
2002
Tongue
English
Weight
227 KB
Volume
20
Category
Article
ISSN
0914-8779

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Rationale for active vitamin D and analo
✍ Yasuho Nishii πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 114 KB

## Abstract In 1981, Chugai Pharmaceutical succeeded in marketing alfacalcidol, a prodrug of calcitriol, as a therapeutic agent for renal osteodystrophy. In 1983, Chugai succeeded in extending the application of alfacalcidol to the treatment of osteoporosis as well. Clinicians in Japan have accepte

Evidence for tissue- and cell-type selec
✍ Sara Peleg; Ayesha Ismail; Milan R. Uskokovic; Zafrira Avnur πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 242 KB

## Abstract Our recent studies have shown that the vitamin D analog Ro‐26‐9228 restores bone mineral density without inducing hypercalcemia in osteopenic rats. Our ex vivo experiments demonstrated that the analog upregulated gene expression in trabecular bone but not in the duodenum of female rats.

Suppression of PTH by the vitamin D anal
✍ Cynthia S. Ritter; Dr. Alex J. Brown πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 129 KB πŸ‘ 1 views

## Abstract Eldecalcitol [1Ξ±,25‐dihydroxy‐2β‐(3‐hydroxypropyloxy)vitamin D~3~], a vitamin D analog with enhanced efficacy for treatment of osteoporosis, has been found to be less potent than 1,25‐dihydroxyvitamin D~3~ (calcitriol) in suppressing PTH in vivo. To define the mechanism for the latter o